A Wireless Pressure Sensor for Monitoring Pulmonary Artery Pressure in Advanced Heart Failure: Initial Experience

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 85-88

  Castro, Pablo F ^a   Concepción, Roberto ^b   Bourge, Robert C ^d   Martínez, Alejandro ^a   Alcaino, Milton ^b   Deck, Carlos ^b   Ferrada, Marcela ^a   Alfaro, Mario ^b   Perrone, Sergio ^c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL DIPRECA   (Chile)

^c FLENI   (Argentina)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASODILATOR AGENT;

AGED; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; MONITORING; PRIORITY JOURNAL; RADIOFREQUENCY; SENSOR; SYMPTOMATOLOGY; VASCULAR ACCESS;

AGED; BLOOD PRESSURE DETERMINATION; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; SEVERITY OF ILLNESS INDEX;

EID: 33846243841     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.006     Document Type: Article

References (24)

1. Felker G.M., Adams K.F., Konstam M.A., O'Connor C.M., and Gheorghiade M. The problem of decompensated heart failure: nomenclature, classification and risk stratification. Am Heart J 145 suppl (2003) S18-S25
2. Heart disease and stroke statistics-2005 update. Dallas, TX: American Heart Association.
3. Fonarow G.C., Stevenson L.W., Walden J.A., et al. Impact of comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. JAMA 30 (1997) 725-732
4. Fonarow G.C., Chelimsky-Fallik C., Stevenson L.W., et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the HyC trial. JAMA 19 (1992) 842-850
5. Rosario L.B., Stevenson L.W., Solomon S.D., Lee R.T., and Reimon S.C. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. JAMA 32 (1998) 1819-1824
6. Stevenson L.W., and Tillish T.H. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation 74 (1986) 1303-1308
7. Stevenson L.W., Sietsema K., Tillish J.H., et al. Exercise capacity for survivors of cardiac transplantation or sustained mediac therapy for stable heart failure. Circulation 81 (1990) 78-85
8. Hamilton M.A., Stevenson L.W., Child J.S., Moriguchi J.D., Walden J., and Woo M. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol 67 (1991) 259-263
9. Stevenson L.W., Brunken R.C., Belil D., et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. JAMA 15 (1990) 174-180
10. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633
11. Lanzarini L., Fontana A., Campana C., and Klersy C. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure. J Heart Lung Transplant 24 (2005) 745-754
12. Stevenson L.W. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail 1 (1999) 251-257
13. Steimle A.E., Stevenson L.W., Chelimsky-Fallick C., et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 96 (1997) 1165-1172
14. Nathan A.W., Perry S.G., Cochrane T., Banim S.O., Spurrell R.A., and Camm A.J. Ambulatory monitoring of pulmonary artery pressure. A preliminary clinical evaluation. Br Heart J 49 (1983) 33-37
15. Gibbs J.S.R., Keegan J., Wright C., Fox K.M., and Poole-Wilson P.A. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. JAMA 15 (1990) 51-61
16. Adamson P.B., Magalski A., Braunschweig F., et al. Ongoing right ventricular hemodynamics in heart failure. Clinical value of measurements derived from an implantable monitoring system. JAMA 41 (2003) 565-571
17. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
18. Stevenson L.W. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail 1 (1999) 251-257
19. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41 (2003) 1797-1804
20. Le Jemtel T.H., and Alt E.U. Hemodynamic goals are outdated. Circulation 113 (2006) 1027-1033
21. Shah M.R., Hasselblad V., Stevenson L.W., et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294 (2005) 1664-1670
22. Nohria A, Shah M, Stebbins A, et al. Effect of empiric versus pulmonary artery catheter-guided therapy on renal function in patients hospitalized with decompensated heart failure. Circulation (in press).
23. Stevenson L.W. Are hemodynamic goals viable in tailoring heart failure therapy?. Hemodynamic goals are relevant. Circulation 113 (2006) 1020-1026
24. Bourge R.C. The Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF) study. Late-Breaking Clinical Trials II (2005), American College of Cardiology Annual Scientific Sessions 2005, Orlando, FL March